Cabergoline is used specifically in protocols involving 19-nor compounds — Nandrolone and Trenbolone — to prevent or manage prolactin-related side effects. Prolactin gynecomastia does not respond to aromatase inhibitors or SERMs the way estrogen-mediated gynecomastia does. Cabergoline addresses the actual mechanism. It is also used to manage the se...
Cabergoline is added specifically when Nandrolone Decanoate, NPP, or Trenbolone are part of the stack. It is not needed alongside testosterone-only protocols or compounds that do not elevate prolactin. It pairs with Anastrozole or Exemestane in 19-nor stacks where both estrogen and prolactin management are required simultaneously. Running it withou...
Cabergoline's dopaminergic activity produces compulsive behavior in a small subset of users — impulse control issues including compulsive gambling and hypersexuality have been documented in Parkinson's patients using higher doses. At performance doses these effects are rare but not absent. Cardiovas...